Related Experiment Video

Updated: Jun 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[Moderate impairment of renal function and cardiovascular risk]

P Fesler1, J Ribstein

  • 1Service de médecine interne et hypertension artérielle, hôpital Lapeyronie, 371, avenue Doyen-G.-Giraud, 34295 Montpellier cedex 5, France. p-fesler@chu-montpellier.fr

La Revue De Medecine Interne
|May 19, 2009
PubMed

Insights

A moderate decrease in kidney function, indicated by reduced glomerular filtration rate (GFR) or microalbuminuria, significantly increases cardiovascular (CV) risk. This association is independent of traditional risk factors, highlighting the need for early detection and management in high-risk individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Context:

  • Increasing prevalence of chronic kidney disease (CKD) in developed nations.
  • Established link between declining renal function and elevated cardiovascular (CV) risk.
  • CV risk increases with reduced glomerular filtration rate (GFR) or presence of microalbuminuria, independent of traditional factors.

Purpose:

  • To analyze the relationship between moderate renal function decline and cardiovascular risk.
  • To explore the potential mechanisms underlying this association.
  • To inform primary and secondary prevention strategies for cardiovascular disease in patients with CKD.

Summary:

  • Moderate decreases in GFR or presence of microalbuminuria are linked to increased CV risk.
  • Potential mechanisms include anemia, calcium/phosphate imbalance, inflammation, and impaired large artery function.
  • Estimating GFR and assessing microalbuminuria are crucial for high-risk individuals.

Impact:

  • Highlights the critical role of kidney function assessment in cardiovascular risk stratification.
  • Emphasizes the need for comprehensive management of traditional CV risk factors in CKD patients.
  • Underscores the necessity for further research into targeted therapies to mitigate CV risk in CKD.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...